In vivo > 항암유효성평가지원센터

We have various animal models for efficacy evaluation and mechanism elucidation. Our animal models can be utilized for clinical trials to provide an optimal in vivo efficacy.

List of Models

MODEL

CANCER TYPE

Xenograft

Syngeneic

Subcutaneous 

Bladder

UM-UC-3

Breast

MCF7, MDA-MB-231

4T1, 4T1-Luc-TdTomato

Burkitt’s lymphoma

Raji

Cervix

A431, CaSki

Colon

DLD-1, HCT-8, HCT-15, HCT-116, HT-29, LoVo, RKO, SW620

CT26, MC38

Kidney

SN12C

Leukemia

K562, MV-4-11

Liver

Hep3B, HepG2, Huh7, SK-Hep1

Lung

A549, HCC78, HCC827, NCI-H69, NCI-H209, NCI-H460, NCI-H1299, PC9

LLC1

Melanoma

UACC-62

B16-F10

Ovary

OVCAR-3-Luc

ID8

Pancreas

AsPC-1 (NOG mouse), BxPC-3, MiAPaCa-2

PAN 02

Prostate

DU145, PC3

TRAMP-C1

Stomach

NCI-N87

Orthotopic

Breast

4T1-Luc-TdTomato

Colon

HCT-116-Luc, HT-29-Luc

 

Leukemia

MOLM-13

Lung

A549-Luc

Ovary

ES-2-Luc

ID8-Luc

Pancreas

AsPC-1-Luc, BxPC-3-Luc

Prostate

TRAMP-C1

Metastasis

Breast

4T1-Luc-TdTomato (Intracardiac Injection),

4T1-Luc-TdTomato (Intravenous Injection)

Leukemia

WEHI-3

Ovary

ES-2-Luc (Orthotopic Injection), OVCAR-3-Luc (Intraperitoneal Injection), SK-OV-3-Luc (Intraperitoneal Injection)

Spontaneous Model

Lung

Lung (Mutation: p53/ras)

Genetically Engineered Mouse

Immuno Oncology

CTLA-4 Knock-out Mouse, PD-1 Knock-out Mouse

Lung

Ba/F3/Her2 insertion cell line,
EGFR mutant (L858R+T790M+C797S)-induced lung cancer in mouse

Service

  • Customized test design
  • Tumor growth inhibition/delay test
    • single treatment
    • combination treatment
  • Kaplan-Meier survival test
  • Metastasis inhibition test
  • Radiotherapy response test
  • Histological analysis
    • Tissue preparation, IHC, TUNEL, DNA/RNA/protein extraction
    • Histopathology
  • MOA & POC validation
  • In vivo imaging
    • MRI, PET, PET-MR, CT, Optical imaging 활용 시험
    • PD, tissue distribution

Service example

Evaluation of in vivo anti-cancer efficacy in colorectal cancersubcutaneous xenograft models